Glycaemic efficacy and safety of mealtime faster‐acting insulin aspart administered by injection as compared to insulin aspart in people with diabetes mellitus: A meta‐analysis of randomized controlled trials

A Randomized Trial Evaluating the Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec With or Without Metformin, in Adults With Type 2 Diabetes (Onset 9)

(2020) Wendy S. Lane et al.   DIABETES CARE

Elucidating the Mechanism of Absorption of Fast-Acting Insulin Aspart: The Role of Niacinamide

(2019) Jonas Kildegaard et al.   PHARMACEUTICAL RESEARCH

Fast-Acting Insulin Aspart and the Need for New Mealtime Insulin Analogues in Adults With Type 1 and Type 2 Diabetes: A Canadian Perspective

(2019) Peter Senior et al.   Canadian Journal of Diabetes

Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The onset 7 Trial

(2019) Bruce W. Bode et al.   DIABETES CARE

Efficacy and safety of fast-acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52-week, randomized, treat-to-target, phase III trial

(2018) Chantal Mathieu et al.   DIABETES OBESITY & METABOLISM

Fast-acting insulin aspart versus insulin aspart in the setting of insulin degludec-treated type 1 diabetes: efficacy and safety from a randomized double-blind trial

(2018) John B. Buse et al.   DIABETES OBESITY & METABOLISM

A randomized, multicentre trial evaluating the efficacy and safety of fast‐acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5)

(2018) David C. Klonoff et al.   DIABETES OBESITY & METABOLISM

Plasma insulin profiles after subcutaneous injection: how close can we get to physiology in people with diabetes?

(2015) P. D. Home   DIABETES OBESITY & METABOLISM

Postprandial Blood Glucose Predicts Cardiovascular Events and All-Cause Mortality in Type 2 Diabetes in a 14-Year Follow-Up: Lessons from the San Luigi Gonzaga Diabetes Study

(2011) F. Cavalot et al.   DIABETES CARE